Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Ligand Pharmaceuticals Net Income 2006-2019 | LGND

Ligand Pharmaceuticals net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Ligand Pharmaceuticals Annual Net Income
(Millions of US $)
2018 $143
2017 $13
2016 $-2
2015 $230
2014 $12
2013 $11
2012 $-1
2011 $10
2010 $-10
2009 $-2
2008 $-98
2007 $282
2006 $-32
2005 $-36
Ligand Pharmaceuticals Quarterly Net Income
(Millions of US $)
Q2 2019 $-14
Q1 2019 $666
Q4 2018 $-42
Q3 2018 $67
Q2 2018 $73
Q1 2018 $45
Q4 2017 $-7
Q3 2017 $8
Q2 2017 $6
Q1 2017 $5
Q4 2016 $-3
Q3 2016 $1
Q2 2016 $-6
Q1 2016 $7
Q4 2015 $6
Q3 2015 $199
Q2 2015 $24
Q1 2015 $1
Q4 2014 $7
Q3 2014 $1
Q2 2014 $2
Q1 2014 $2
Q4 2013 $2
Q3 2013 $2
Q2 2013 $6
Q1 2013 $1
Q4 2012 $1
Q3 2012 $-0
Q2 2012 $-3
Q1 2012 $1
Q4 2011 $5
Q3 2011 $-4
Q2 2011 $-0
Q1 2011 $10
Q4 2010 $5
Q3 2010 $-12
Q2 2010 $-0
Q1 2010 $-3
Q4 2009 $3
Q3 2009 $2
Q2 2009 $-2
Q1 2009 $-5
Q4 2008 $-70
Q3 2008 $-18
Q2 2008 $-6
Q1 2008 $-4
Q4 2007 $6
Q3 2007 $1
Q2 2007 $0
Q1 2007 $274
Q4 2006 $141
Q3 2006 $-15
Q2 2006 $-16
Q1 2006 $-142
Q4 2005 $-3
Q3 2005 $-6
Q2 2005 $-9
Q1 2005 $-18
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.745B $0.251B
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.526B 13.61
Gilead Sciences (GILD) United States $79.622B 9.78
Celgene (CELG) United States $66.133B 10.23
Vertex Pharmaceuticals (VRTX) United States $46.554B 50.31
Biogen (BIIB) United States $41.986B 7.46
Illumina (ILMN) United States $41.861B 49.18
CSL (CSLLY) Australia $34.685B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.193B 14.61
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.450B 12.89
Incyte (INCY) United States $17.337B 51.02
Exact Sciences (EXAS) United States $15.308B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.873B 0.00
Genmab (GNMSF) Denmark $12.608B 64.09
Seattle Genetics (SGEN) United States $12.406B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.477B 50.81
Guardant Health (GH) United States $9.197B 0.00
Sarepta Therapeutics (SRPT) United States $9.067B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.715B 0.00
Galapagos (GLPG) Belgium $8.688B 0.00
QIAGEN (QGEN) Netherlands $7.764B 25.50
Bio-Techne Corp (TECH) United States $7.304B 50.48
BeiGene (BGNE) Cayman Islands $6.704B 0.00
Bluebird Bio (BLUE) United States $6.466B 0.00
Exelixis (EXEL) United States $6.040B 15.70
Amarin (AMRN) Ireland $5.158B 0.00
Horizon Pharma Public (HZNP) Ireland $5.004B 12.72
Ascendis Pharma (ASND) Denmark $4.838B 0.00
Repligen (RGEN) United States $4.555B 88.40
ARGENX SE-ADR (ARGX) Netherlands $4.335B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.193B 0.00
Moderna (MRNA) United States $4.183B 0.00
Blueprint Medicines (BPMC) United States $4.014B 0.00
Spark Therapeutics (ONCE) United States $3.853B 0.00
China Biologic Products (CBPO) China $3.821B 23.85
MorphoSys AG (MOR) Germany $3.777B 0.00
Mirati Therapeutics (MRTX) United States $3.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.281B 0.00
Alkermes (ALKS) Ireland $3.276B 0.00
Immunomedics (IMMU) United States $2.759B 0.00
Genomic Health (GHDX) United States $2.752B 51.61
Arena Pharmaceuticals (ARNA) United States $2.635B 5.66
NeoGenomics (NEO) United States $2.549B 136.33
Amicus Therapeutics (FOLD) United States $2.544B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.520B 0.00
Medicines (MDCO) United States $2.501B 0.00
MyoKardia (MYOK) United States $2.460B 0.00
Acceleron Pharma (XLRN) United States $2.372B 0.00
Halozyme Therapeutics (HALO) United States $2.319B 0.00
Emergent Biosolutions (EBS) United States $2.223B 33.40
Reata Pharmaceuticals (RETA) United States $2.197B 0.00
UniQure (QURE) Netherlands $2.120B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.113B 0.00
Cambrex (CBM) United States $2.012B 25.43
Zai Lab (ZLAB) China $1.944B 0.00
Akcea Therapeutics (AKCA) United States $1.914B 0.00
Myriad Genetics (MYGN) United States $1.714B 17.98
Denali Therapeutics (DNLI) United States $1.689B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.585B 0.00
Insmed (INSM) United States $1.382B 0.00
AnaptysBio (ANAB) United States $1.352B 0.00
RA PHARMCTL INC (RARX) United States $1.350B 0.00
REGENXBIO (RGNX) United States $1.308B 0.00
Coherus BioSciences (CHRS) United States $1.291B 0.00
Sangamo Therapeutics (SGMO) United States $1.278B 0.00
Editas Medicine (EDIT) United States $1.256B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.212B 0.00
Epizyme (EPZM) United States $1.168B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.165B 0.00
Fate Therapeutics (FATE) United States $1.150B 0.00
Athenex (ATNX) United States $1.145B 0.00
Innoviva (INVA) United States $1.136B 3.28
Alector (ALEC) United States $1.023B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.997B 0.00
Zymeworks (ZYME) Canada $0.979B 0.00
Twist Bioscience (TWST) United States $0.938B 0.00
Cara Therapeutics (CARA) United States $0.900B 0.00
Principia Biopharma (PRNB) United States $0.868B 452.88
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.821B 0.00
Intellia Therapeutics (NTLA) United States $0.820B 0.00
ANI Pharmaceuticals (ANIP) United States $0.812B 13.55
Adverum Biotechnologies (ADVM) United States $0.804B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.794B 28.67
Arvinas (ARVN) United States $0.783B 0.00
Codexis (CDXS) United States $0.777B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.774B 0.00
Anika Therapeutics (ANIK) United States $0.760B 26.90
Cytokineticsorporated (CYTK) United States $0.733B 0.00
Retrophin (RTRX) United States $0.730B 0.00
Pharming Group (PHGUF) Netherlands $0.730B 0.00
WAVE Life Sciences (WVE) Singapore $0.697B 0.00
Vericel (VCEL) United States $0.688B 0.00
Zealand Pharma (ZLDPF) Denmark $0.672B 0.00
Zealand Pharma (ZEAL) Denmark $0.670B 7.77
Achillion Pharmaceuticals (ACHN) United States $0.659B 0.00
Stemline Therapeutics (STML) United States $0.634B 0.00
Heska (HSKA) United States $0.561B 72.73
MiMedx (MDXG) United States $0.555B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.535B 0.00
DBV Technologies S.A (DBVT) France $0.529B 0.00
Intra-Cellular Therapies (ITCI) United States $0.498B 0.00
Cellectis S.A (CLLS) France $0.489B 0.00
Revance Therapeutics (RVNC) United States $0.481B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.452B 0.00
Precision BioSciences (DTIL) United States $0.445B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
UROGEN PHARMA (URGN) United States $0.429B 0.00
Syros Pharmaceuticals (SYRS) United States $0.418B 0.00
CytomX Therapeutics (CTMX) United States $0.412B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.402B 0.00
BioDelivery Sciences (BDSI) United States $0.385B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Agenus (AGEN) United States $0.380B 0.00
PHARMA MAR SA (PHMMF) Spain $0.374B 0.00
Merus (MRUS) Netherlands $0.369B 0.00
Puma Biotechnology (PBYI) United States $0.367B 0.00
Avid Bioservices (CDMO) United States $0.360B 0.00
AC Immune SA (ACIU) Switzerland $0.347B 25.70
Arcus Biosciences (RCUS) United States $0.326B 0.00
Gritstone Oncology (GRTS) United States $0.323B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Bellus Health (BLUSF) Canada $0.314B 0.00
Starpharma Holdings (SPHRY) Australia $0.310B 0.00
Kadmon Holdings (KDMN) United States $0.310B 0.00
Scholar Rock Holding (SRRK) United States $0.309B 0.00
Theratechnologies (THERF) Canada $0.308B 0.00
Prothena (PRTA) Ireland $0.303B 0.00
PDL BioPharma (PDLI) United States $0.291B 7.50
Clovis Oncology (CLVS) United States $0.284B 0.00
Albireo Pharma (ALBO) United States $0.282B 0.00
Kindred Biosciences (KIN) United States $0.272B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.271B 0.00
Sorrento Therapeutics (SRNE) United States $0.271B 0.00
Protagonist Therapeutics (PTGX) United States $0.263B 0.00
Geron (GERN) United States $0.262B 0.00
Dynavax Technologies (DVAX) United States $0.255B 0.00
Senesco Technologies (ELOX) United States $0.247B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.242B 0.00
Cellular Biomedicine (CBMG) United States $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.231B 0.00
ChromaDex (CDXC) United States $0.231B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.225B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.225B 0.00
Inovio Pharmaceuticals (INO) United States $0.217B 0.00
Kamada (KMDA) Israel $0.212B 8.09
Five Prime Therapeutics (FPRX) United States $0.211B 0.00
PHASEBIO PHARMA (PHAS) United States $0.204B 0.00
Seres Therapeutics (MCRB) United States $0.199B 0.00
MannKind (MNKD) United States $0.197B 0.00
Sutro Biopharma (STRO) United States $0.196B 0.00
Athersys (ATHX) United States $0.188B 0.00
Compugen (CGEN) Israel $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Cue Biopharma (CUE) United States $0.171B 0.00
Affimed (AFMD) Germany $0.168B 0.00
POXEL SA FRANCE (PXXLF) $0.167B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Novavax (NVAX) United States $0.158B 0.00
Emmaus Life Sciences (EMMA) United States $0.157B 0.00
Cerecor (CERC) United States $0.154B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.153B 0.00
Arsanis (XFOR) United States $0.152B 0.00
Nicox SA (NICXF) France $0.150B 0.00
OSMOTICA PHARM (OSMT) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.147B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.147B 0.00
XOMA (XOMA) United States $0.144B 0.00
Synlogic (SYBX) United States $0.143B 0.00
Strongbridge Biopharma (SBBP) United States $0.140B 5.76
Lexicon Pharmaceuticals (LXRX) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Mersana Therapeutics (MRSN) United States $0.132B 0.00
Prometic Life Sciences (PFSCF) Canada $0.130B 0.00
Acorda Therapeutics (ACOR) United States $0.126B 0.00
Alcobra (ARCT) United States $0.126B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
NantKwest (NK) United States $0.122B 0.00
Northwest Biotherapeutics (NWBO) United States $0.120B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
Aptinyx (APTX) United States $0.110B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
Abeona Therapeutics (ABEO) United States $0.107B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.107B 0.00
Fortress Biotech (FBIO) United States $0.106B 0.00
TOCAGEN INC (TOCA) United States $0.104B 0.00
Checkpoint Therapeutics (CKPT) United States $0.103B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.091B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.087B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.085B 0.00
Trevena (TRVN) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Menlo Therapeutics (MNLO) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Curis (CRIS) United States $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
Antibe Therapeutics (ATBPF) Canada $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
VBI Vaccines (VBIV) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 30.00
Prima BioMed (IMMP) Australia $0.054B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Unum Therapeutics (UMRX) United States $0.054B 0.00
Invo BioScience (IVOB) United States $0.051B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.039B 0.00
VIVUS (VVUS) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.036B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.033B 0.00
Proteostasis Therapeutics (PTI) United States $0.032B 0.00
Celldex Therapeutics (CLDX) United States $0.032B 0.00
BIOCARDIA INC (BCDA) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Soligenix (SNGX) United States $0.021B 0.00
VistaGen Therapeutics (VTGN) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Vical (VICL) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.013B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
TrovaGene (TROV) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
Neuralstem (CUR) United States $0.002B 0.00